Daniel Kraft, MD - among the nation’s most prolific, multi-dimensional, and “applied healthcare" futurists - is a Stanford- and Harvard-trained physician-scientist with over 20 years of experience in clinical practice, biomedical research, and healthcare innovation. He is a serial entrepreneur, educator, inventor/developer of medical devices, drug therapies, and telecommunications systems.

Currently, Daniel is the Founder and CEO of IntelliMedicine, which focuses on enabling connected, data-driven, and integrated personalized medicine. He also chairs the Medicine Track for Singularity University and is Executive Director of its FutureMed Program, which educates, informs, and prepares physicians and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare, and to understand how many rapidly developing and converging fields affect the future of clinical practice and the biomedical industry.

Daniel is also a Venture Partner with Proteus Venture Partners, and has served as an advisor to CollabRx (personalized oncology), Wellsphere (general health and wellness), Cepheid (point-of-care diagnostics), and the X Prize Foundation (life sciences). He invented the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies. He built the first Internet-based alphanumeric paging system at the Stanford hospitals to facilitate communication between clinical staff. In research at the National Institutes of Health, Daniel conceived of and demonstrated proof of concept for a monoclonal antibody-based therapy for treating allergic disease; his general approach was later translated to an antibody Xolair therapeutic by Genentech.

Following undergraduate degrees from Brown University and the completion of medical school at Stanford, Daniel was board certified in both Internal Medicine and Pediatrics, following residency at the Massachusetts General Hospital, and completed Stanford fellowships in hematology/oncology and bone marrow transplantation, and extensive research in stem cell biology and regenerative medicine. He has multiple scientific publications, medical device, immunology and stem cell-related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California San Francisco.

Daniel is an avid pilot and serves in the California Air National guard as an officer and flight surgeon with an F-16 Squadron. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.